BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 17883173)

  • 21. Prognostic value of AML 1/ETO fusion transcripts in patients with acute myelogenous leukemia.
    Cho EK; Bang SM; Ahn JY; Yoo SM; Park PW; Seo YH; Shin DB; Lee JH
    Korean J Intern Med; 2003 Mar; 18(1):13-20. PubMed ID: 12760263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting of AML1-ETO in t(8;21) leukemia by oridonin generates a tumor suppressor-like protein.
    Zhen T; Wu CF; Liu P; Wu HY; Zhou GB; Lu Y; Liu JX; Liang Y; Li KK; Wang YY; Xie YY; He MM; Cao HM; Zhang WN; Chen LM; Petrie K; Chen SJ; Chen Z
    Sci Transl Med; 2012 Mar; 4(127):127ra38. PubMed ID: 22461642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. New mechanisms of AML1 gene alteration in hematological malignancies.
    Roumier C; Fenaux P; Lafage M; Imbert M; Eclache V; Preudhomme C
    Leukemia; 2003 Jan; 17(1):9-16. PubMed ID: 12529654
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring the AML1/ETO fusion transcript to predict outcome in childhood acute myeloid leukemia.
    Zhang L; Cao Z; Ruan M; Zeng Q; Zhao L; Li Q; Zou Y; Wang J; Zhu X
    Pediatr Blood Cancer; 2014 Oct; 61(10):1761-6. PubMed ID: 24920269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Variant translocation t(2;21;8)(q36;q22;q22) with RUNX1/CBFA2T1 (AML1/ETO) transcript in a case of acute myelogenous leukemia.
    Hsiao HH; Sashida G; Kodama A; Fukutake K; Ohyashiki K
    Cancer Genet Cytogenet; 2005 May; 159(1):96-7. PubMed ID: 15860366
    [No Abstract]   [Full Text] [Related]  

  • 26. Complex translocation (8;12;21): a new variant of t(8;21) in acute myeloid leukemia.
    Farra C; Awwad J; Valent A; Lozach F; Bernheim A
    Cancer Genet Cytogenet; 2004 Dec; 155(2):138-42. PubMed ID: 15571799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AML1-ETO triggers epigenetic activation of early growth response gene l, inducing apoptosis in t(8;21) acute myeloid leukemia.
    Fu L; Huang W; Jing Y; Jiang M; Zhao Y; Shi J; Huang S; Xue X; Zhang Q; Tang J; Dou L; Wang L; Nervi C; Li Y; Yu L
    FEBS J; 2014 Feb; 281(4):1123-31. PubMed ID: 24314118
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical and biological characteristics in childhood acute myeloid leukemia with 8;21 translocation].
    He J; Xue Y; He H; Li J; Song X; Huang Y; He Y; Zhang X; Chai Y; Zhu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):512-4. PubMed ID: 15476184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AML1/ETO proteins control POU4F1/BRN3A expression and function in t(8;21) acute myeloid leukemia.
    Dunne J; Gascoyne DM; Lister TA; Brady HJ; Heidenreich O; Young BD
    Cancer Res; 2010 May; 70(10):3985-95. PubMed ID: 20460523
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Analysis of 21 children with acute non-lymphoid leukemia carrying AML1/ETO fusion gene].
    Zhao W; Li ZG; Wu MY; Geng LZ; Shi HW; Zhang YH; Wu RH
    Zhonghua Er Ke Za Zhi; 2003 May; 41(5):325-8. PubMed ID: 14751048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. JAK2 seems to be a typical cooperating mutation in therapy-related t(8;21)/ AML1-ETO-positive AML.
    Schnittger S; Bacher U; Kern W; Haferlach C; Haferlach T
    Leukemia; 2007 Jan; 21(1):183-4. PubMed ID: 17096014
    [No Abstract]   [Full Text] [Related]  

  • 32. Leukemogenic AML1-ETO fusion protein increases carcinogen-DNA adduct formation with upregulated expression of cytochrome P450-1A1 gene.
    Xu M; Li D; Lu Y; Chen GQ
    Exp Hematol; 2007 Aug; 35(8):1249-55. PubMed ID: 17560011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The leukemogenic t(8;21) fusion protein AML1-ETO controls rRNA genes and associates with nucleolar-organizing regions at mitotic chromosomes.
    Bakshi R; Zaidi SK; Pande S; Hassan MQ; Young DW; Montecino M; Lian JB; van Wijnen AJ; Stein JL; Stein GS
    J Cell Sci; 2008 Dec; 121(Pt 23):3981-90. PubMed ID: 19001502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pontin is a critical regulator for AML1-ETO-induced leukemia.
    Breig O; Bras S; Martinez Soria N; Osman D; Heidenreich O; Haenlin M; Waltzer L
    Leukemia; 2014 Jun; 28(6):1271-9. PubMed ID: 24342949
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 8;21 translocation in leukemogenesis.
    Peterson LF; Zhang DE
    Oncogene; 2004 May; 23(24):4255-62. PubMed ID: 15156181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.
    Hackanson B; Abdelkarim M; Jansen JH; Lübbert M
    Leukemia; 2010 Apr; 24(4):860-1. PubMed ID: 20090777
    [No Abstract]   [Full Text] [Related]  

  • 37. High degree of myeloid differentiation and granulocytosis is associated with t(8;21) smoldering leukemia.
    Yamasaki H; Era T; Asou N; Sanada I; Matutes E; Yamaguchi K; Takatsuki K
    Leukemia; 1995 Jul; 9(7):1147-53. PubMed ID: 7630188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expression of AML1/ETO9a isoform in acute myeloid leukemia-M2 subtype].
    Miao YQ; Chen ZX; He J; Cen JN; Bao XJ; Qiu QC; Zhang DE; Yan M
    Zhonghua Xue Ye Xue Za Zhi; 2007 Jan; 28(1):27-9. PubMed ID: 17649722
    [TBL] [Abstract][Full Text] [Related]  

  • 39. AML1-ETO and C-KIT mutation/overexpression in t(8;21) leukemia: implication in stepwise leukemogenesis and response to Gleevec.
    Wang YY; Zhou GB; Yin T; Chen B; Shi JY; Liang WX; Jin XL; You JH; Yang G; Shen ZX; Chen J; Xiong SM; Chen GQ; Xu F; Liu YW; Chen Z; Chen SJ
    Proc Natl Acad Sci U S A; 2005 Jan; 102(4):1104-9. PubMed ID: 15650049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel variant translocation t(6;8;21)(p22;q22;q22) leading to AML/ETO fusion in acute myeloid leukemia.
    Al Bahar S; Adriana Z; Pandita R
    Gulf J Oncolog; 2009 Jan; (5):56-9. PubMed ID: 20084788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.